Can a tablet break the language barrier in emergencies?

NCT ID NCT06322004

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 38 times

Summary

This study tests whether using a tablet for live video interpreting helps emergency doctors communicate with patients who don't speak the same language. Fifty awake adult patients with language barriers will be included. The researchers will measure how well the technology works, how easy it is to use, and whether it changes the doctor's diagnosis or treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMMUNICATION BARRIERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medical University of Vienna

    RECRUITING

    Vienna, 1090, Austria

    Contact Email: •••••@•••••

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

video-interpreting via tablet

What this could lead to

If successful, this could show that video interpreting is a practical tool for emergency doctors to overcome language barriers, potentially improving care for non-native speakers.

What could go wrong

This is a small feasibility study with only 50 patients, so results may not apply broadly. Technical problems or patient refusal could limit its usefulness.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.